Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 166

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

143	NVLX Creeping up the ladder!	stocklegend	01/13/2014 10:26:46 AM
142	All recent NVLX financial information can be	Tandrel	01/13/2014 10:17:56 AM
141	NVLX investors relations information Marlin	Tandrel	01/13/2014 10:16:44 AM
140	NVLX news	stocklegend	01/13/2014 9:56:52 AM
139	NVLX NEWS OUT:	stocklegend	01/13/2014 9:38:48 AM
138	NVLX~ Up Trend Galore!	stocklegend	01/13/2014 9:11:37 AM
137	NVLX~	stocklegend	01/13/2014 8:50:13 AM
136	Nuvilex Listed in Forbes Article on Biotech	stocklegend	12/20/2013 3:25:32 PM
135	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	12/20/2013 3:13:04 PM
134	$NVLX Nuvilex COO Talks About Companys	stocklegend	12/20/2013 2:19:50 PM
133	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	12/20/2013 1:52:41 PM
132	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	12/20/2013 1:38:48 PM
131	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	12/20/2013 1:15:52 PM
130	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/20/2013 12:53:16 PM
129	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/20/2013 12:52:02 PM
128	NVLX news:	stocklegend	12/20/2013 12:24:45 PM
127	$NVLX Nuvilex Accelerates Development of	stocklegend	12/20/2013 12:21:15 PM
126	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	12/20/2013 11:55:26 AM
125	Nuvilex Ahead of the Curve on Cannabidiol as FDA	stocklegend	12/20/2013 11:39:00 AM
124	$NVLX Investors Confidently Back Nuvilex's	stocklegend	12/20/2013 11:02:20 AM
123	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	12/20/2013 10:35:41 AM
121	After Pancreatic Cancer, Eli Lilly and Nuvilex	stocklegend	12/20/2013 10:25:08 AM
120	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	12/20/2013 9:51:58 AM
119	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	12/20/2013 9:25:18 AM
118	Nuvilex Begins Making Moves at its Medical	stocklegend	12/20/2013 9:08:55 AM
117	Nuvilex's Medical Marijuana Subsidiary Appoints	stocklegend	12/20/2013 8:57:36 AM
116	$NVLX Nuvilex Accelerates Development of	stocklegend	12/19/2013 3:35:05 PM
115	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/19/2013 3:13:24 PM
114	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	12/19/2013 2:35:25 PM
113	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	12/19/2013 2:07:32 PM
112	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	12/19/2013 1:48:19 PM
111	$NVLX Nuvilex COO Talks About Companys	stocklegend	12/19/2013 1:24:39 PM
110	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	12/19/2013 12:49:08 PM
109	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	12/19/2013 12:33:40 PM
108	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	12/19/2013 12:02:53 PM
107	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	12/19/2013 11:36:47 AM
106	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	12/19/2013 11:10:29 AM
105	NVLX News Out:	stocklegend	12/19/2013 10:26:09 AM
104	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	12/19/2013 10:24:49 AM
103	$NVLX - Nuvilex Restructures its Operations to	stocklegend	12/19/2013 10:06:56 AM
102	$NVLX - Nuvilex Restructures to Focus on	stocklegend	12/19/2013 9:29:30 AM
101	Nuvilex Contracts with Inno Biologics to Clone	stocklegend	12/19/2013 9:17:36 AM
100	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	12/19/2013 8:48:26 AM
99	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	12/18/2013 2:22:14 PM
98	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	12/18/2013 1:52:45 PM
97	Nuvilex Announces Cloning of Cells for Phase 3	stocklegend	12/18/2013 1:28:59 PM
96	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/18/2013 1:16:18 PM
95	$NVLX Nuvilex Accelerates Development of	stocklegend	12/18/2013 12:44:59 PM
94	Nuvilex's Acquisition of Diabetes Rights Should	stocklegend	12/18/2013 12:26:46 PM
93	$NVLX Nuvilex Ahead of the Curve on	stocklegend	12/18/2013 12:01:07 PM

Newer

Older

Recent Articles

• Exploring Culinary Delights at the China Supply Chain Show
• High Arctic Overseas Reports Q3 2024 Financial Highlights
• Grab Unmissable Offers Before Monport's Black Friday Ends
• Canadian Spirit Resources Highlights First Quarter Financials
• Innovation at the Expo: Where Sci-Fi Meets Reality
• Rakovina Therapeutics Reports Q3 Financial Progress and Innovations
• Innovative Transportation Concepts at the China Supply Chain Expo
• Exploring Hotpot Culture at the China International Supply Chain Expo
• CBC Group and Mubadala Form NeuroGen Pharma for Growth
• GVD Markets Launches Global Expansion with Unique Trading Solutions
• CBC Group and Mubadala Form NeuroGen Pharma in China Deal
• Hampton Financial Corporation Distributes Stock Options for Growth
• Tice Family Takes Stand for Journalist in Press Conference
• ProMortgage Expands Team With Four Experienced Professionals
• Unlock Seamless Communication with iFLYTEK's Smart Translator
• Investor Alert: Acadia Healthcare Class Action Insights
• O2Gold Expands Acquisition Plans for Quebec Aur Property
• Brazil Potash Celebrates Successful Initial Public Offering
• ISS Endorses Director Nominees for Carver Bancorp, Inc.
• Deadline for Shareholder Distribution Approval Announced by LWP
• Axis Auto Finance Inc. Annual Meeting Voting Results Overview
• Fluent, Inc. Secures $5.75 Million Through Direct Offerings
• The Future of Silicon Photonics: Trends and Insights for Growth
• Expansion of Managed Services Market in Saudi Arabia Forecasted
• Cloud ERP Market Growth Driven by AI and Digital Transformation
• Exploring the Growth of the Titanium Market and AI's Impact
• Syntheia: Transforming Customer Engagement with AI Solutions
• Photonics Market Growth Forecast: Major Innovations Ahead
• Strategic Management Transition at Premier American Uranium
• Financial Overview of Patagonia Gold for Q3 2024
• First Savings Financial Group Declares Quarterly Dividend for 2024
• Anoto Group Introduces Its Latest Prospectus for Investment Opportunities
• Inovalis REIT Moves Forward with €18.2 Million Property Sale
• State Street Leadership Prepares for Goldman Sachs Conference
• XTM Inc. Celebrates Impressive Q3 2024 Performance with Growth
• Investors Excited for Lightspeed's Upcoming Conference Participation
• Emerging Trends in Cannabis Testing Market Boost Growth
• Halmont Properties' Strong Q3 Performance and Future Outlook
• Brookfield Infrastructure Announces Major Subordinated Note Deal
• Investigation Launched Against Customers Bancorp, Inc. Amid Losses
• Red White & Bloom Achieves Major Growth in Q3 Financials
• Cue Biopharma Welcomes New Chief Development Officer
• WeRide Inc. Launches GXR Robotaxi Platform and Strategic Growth
• Aspen Insurance's Preference Shares Redemption Announcement
• Chemours Successfully Reprices U.S. Dollar Term Loan Facility
• Understanding the Walgreens Boots Alliance Shareholder Settlement
• Innovative Mobile MRI Scanner Revolutionizes Healthcare Imaging
• Amgen Leadership Set to Speak at Key Healthcare Conference
• JB Perrette to Share Insights at Upcoming TMT Summit Event
• Neuberger Berman Real Estate Fund Declares Monthly Dividend